Anlito, Sandro M.
HRN: 23-58-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
MUPIROCIN 2%, 15G (TUBE)
08/30/2023
09/06/2023
TOPICAL
15g
BID
Rashes
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes